COSMOS Pharmaceutical Corporation (TYO:3349)
Japan · Delayed Price · Currency is JPY 9,122.00
+110.00 (1.22%)
Sep 10, 2025, 3:30 PM JST
COSMOS Pharmaceutical Revenue
In the fiscal year ending May 31, 2025, COSMOS Pharmaceutical had annual revenue of 1.01T JPY with 4.81% growth. COSMOS Pharmaceutical had revenue of 259.12B in the quarter ending May 31, 2025, with 3.78% growth.
Revenue
1,011.39B
Revenue Growth
+4.81%
P/S Ratio
0.71
Revenue / Employee
177.16M
Employees
5,709
Market Cap
714.27B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| May 31, 2025 | 1,011.39B | 46.40B | 4.81% |
| May 31, 2024 | 964.99B | 137.29B | 16.59% |
| May 31, 2023 | 827.70B | 72.28B | 9.57% |
| May 31, 2022 | 755.41B | 28.99B | 3.99% |
| May 31, 2021 | 726.42B | 42.02B | 6.14% |
| May 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Chugai Pharmaceutical | 1,196.21B |
| Takeda Pharmaceutical Company | 4,480.25B |
| HOYA Corporation | 876.09B |
| Daiichi Sankyo Company | 1,924.68B |
| Otsuka Holdings | 2,401.70B |
| Terumo | 1,037.94B |
| Astellas Pharma | 1,944.99B |
| Shionogi & | 440.50B |